Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1998 Jan;45(1):1-12.
doi: 10.1046/j.1365-2125.1998.00640.x.

Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications

A Gescher  1 , U Pastorino, S M Plummer, M M Manson
Affiliations
Review

Suppression of tumour development by substances derived from the diet--mechanisms and clinical implications

A Gescher et al. Br J Clin Pharmacol. 1998 Jan.

Abstract

The concept that cancer can be prevented, or its onset postponed, by certain diet-derived substances is currently eliciting considerable interest. Agents which interfere with tumour development at the stage of promotion and progression in particular are of potential clinical value. As chemopreventive agents have to be administered over a long period of time in order to establish whether they possess efficacy in humans, it is of paramount importance to establish their lack of toxicity. The desire to select the best chemopreventive drug candidates for clinical trial, and the necessity to monitor efficacy in the short and intermediate term, render the identification of specific mechanism-based in vivo markers of biological activity a high priority. Antioxidation, inhibition of arachidonic acid metabolism, modulation of cellular signal transduction pathways, inhibition of hormone and growth factor activity and inhibition of oncogene activity are discussed as mechanisms by which the soya constituent genistein, the curry ingredient curcumin and the vitamin A analogue 13-cis retinoic acid exert tumour suppression. A better understanding of these mechanisms will help the establishment of screens for the discovery of new and better chemopreventive agents and the identification of surrogate markers to assess the outcome of clinical chemoprevention trials.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Hypothetical phases of multistep carcinogenesis.
Figure 2
Figure 2
Structures of tumour-suppressive agents.
Figure 3
Figure 3
Signalling pathways which are known to be subject to pharmacological manipulation [modified from 99]. In this hypothetical scheme the initial signal is considered to be a growth factor or other ligand interacting with a cell surface receptor. The receptor acts as the originating detector for the signal, which is subsequently transduced to produce second messengers to bring about biological responses. Specific examples of components of signalling pathways which can be influenced by cancer chemopreventive agents and which are mentioned in the text are shown below the boxes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Weinstein IB. Cancer prevention: recent progress and future opportunities. Cancer Res. 1991;51:5080s–5085s. - PubMed
    1. Wattenberg LW. Chemoprophylaxis of carcinogenesis: A review. Cancer Res. 1966;26:1520–1526. - PubMed
    1. Ruddon RW. Cancer Biology. Oxford University Press; 1995.
    1. Wattenberg LW. Chemoprevention of cancer. Cancer Res. 1985;45:1–8. - PubMed
    1. Kelloff GJ, Boone CW, Crowell JA, et al. Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev. 1994;3:85–98. - PubMed
-